The Health 2030 Genome Center announced the appointment of Alexandre Reymond as its new Director. With decades of experience in genomics and a proven track record of fostering scientific excellence, Prof Reymond will lead the center into its next phase of growth and discovery.
The Health 2030 Genome Center, located at Biotech Campus, site of Switzerland Innovation Park West EPFL, plays a critical role in large-scale genome sequencing, data analysis, and interpretation for both clinical diagnostics and biomedical research. It is home to the DNA Sequencing Platform (DSP), which delivers cost-efficient, high-throughput sequencing services, and the Data Analytics and Interpretation Platform (DAIP), which provides cutting-edge computational analysis to support genome-driven insights.
Beyond research, the Genome Center serves as a big data hub for Switzerland’s growing genomic needs, offering educational programs for scientists, healthcare professionals, and the public. Institutions collaborating under the Health 2030 Initiative include EPFL, UNIGE, HUG, UNIL, CHUV, UNIBE, and Inselspital, ensuring a strong network of expertise and shared innovation.
Prof Reymond brings an exceptional academic and research background to the role, being a prominent figure in the field of human genetics. He is internationally recognized for his groundbreaking work on structural variation and its impact on human health and disease. Previously, he held the position of Director at the Center for Integrative Genomics (CIG) at the University of Lausanne, where he has played a pivotal role in advancing genomic research and education. He was the President of the European Society of Human Genetics between 2019 and 2021 (ESHG).
“It is an honor to join the Health 2030 Genome Center at such a transformative time for genomics,” said Prof Reymond. “The Center’s commitment to innovation and interdisciplinary collaboration aligns with my vision for leveraging genomic science to address global health challenges. Together with the talented Health 2030 Genome Center team, I look forward to driving impactful research and delivering solutions that will improve health outcomes.”
Prof Reymond’s appointment signals a renewed commitment to expanding the center’s contributions to international genomics efforts while maintaining its strong focus on Swiss public health priorities.
The Board of Directors expressed their confidence in Prof Reymond’s ability to guide the center into a new era.